It is not uncommon for patients who’ve been diagnosed with cancer to feel stigmatized for behaviors that could have led to their disease, such as smoking or tanning.

When Baltimore Veterans Affairs (VA) Medical Center expanded its mammography screening program in 2008 to cater to a growing number of female veterans, the hope was that the interval from diagnosis to treatment would decrease. However, time to treatment actually grew longer with increased volumes in the post-intervention period.

The Advanced Medical Technology Association (AdvaMed) today released a new study on pricing trends for implantable medical devices that shows average prices have declined significantly for major categories of implantable medical devices from 2007 through 2011."These average pricing declines reflect the intensely competitive marketplace for medical technology and underscore the tremendous value devices and diagnostics provide to patients and the overall health care system," said Stephen J. Ubl, president and CEO of AdvaMed.

Given Imaging Ltd, (NASDAQ: GIVN), a world leader in gastrointestinal medical devices and pioneer of capsule endoscopy, today announced that Japan's Pharmaceuticals and Medical Devices Agency (PMDA) has granted approval for the PillCam SB 3 system<http://youtu.be/IOk5tF3pUKQ>.  The innovative technology in this third-generation system will provide physicians throughout Japan, the world's second largest healthcare market, with the most advanced PillCam capsule endoscopy technology to detect and monitor small bowel diseases, such as Crohn's disease.

Nucletron, an Elekta company, and the world leader in brachytherapy, has launched Esteya®, a new approach for treating patients with skin cancer.Over the last 30 years, more people were diagnosed with skin cancer worldwide than all other cancers combined, making it the most common type of cancer1. This represents a challenge for health care providers in the years to come. With a cure rate of more than 95 percent2, electronic brachytherapy offers a refined treatment modality with excellent cosmesis.

The AcuPulse DUO addresses a broad range of clinical solutions for ear, nose and throat, gynecology, otology and general surgery. Combined with its full range of fiber and free beam accessories, it is a powerful surgical tool. Additionally, three power modes, three timed-exposure modes and the SurgiTouch scanner give surgeons the freedom to customize beam delivery and control tissue effect for optimal balance between surgical precision and microvascular hemostasis.

Visualization of Parkinson’s disease (PD) development may now be possible by identifying dopaminergic nigrosomes, or the lack thereof, according to a study published Aug. 6 in Neurology

The 2013 World Molecular Imaging Congress (WMIC) held Sept. 18-21 in Savannah, Ga., highlighted biomarker clinical trials, diabetes and brain research, advances in technology and a program that encouraged emerging experts, say World Molecular Imaging Society leaders in an exclusive interview with Molecular Imaging.